NY authorities say $170M pill ring shut down

Authorities say they've shut down several New York City medical clinics and arrested two dozen people in a scheme to sell more than 5 million prescription painkillers on the black market.

The arrests were announced on Wednesday by the U.S. attorney's office in Manhattan and the New York City special narcotics prosecutor.

Investigators say the pill ring relied on corrupt physicians who wrote thousands of unnecessary prescriptions for highly addictive oxycodone since 2011. They say the 5 million pills had a street value of at least $170 million.

Prosecutors say unruly crowds of people formed each morning at a Bronx clinic to pay up to $300 to see a doctor, who would then give them oxycodone prescriptions without doing exams.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Sales of oxycodone by doctors fall in Florida

Feb 02, 2012

The number of oxycodone pills sold by Florida doctors dropped dramatically in 2011, following a series of high-profile arrests and a legislative crackdown on the storefront "pill mills" that made South Florida the hub of ...

DEA settles Walgreens painkiller case for $80M

Jun 11, 2013

The U.S. Drug Enforcement Administration has reached an $80 million civil settlement with the Walgreens pharmacy chain over violations of rules governing the distribution of powerful prescription painkillers.

Deaths from painkiller overdose triple in decade

Nov 01, 2011

The number of overdose deaths from powerful painkillers more than tripled over a decade, the government reported Tuesday - a trend that a U.S. health official called an epidemic, but one that can be stopped.

Recommended for you

Expression of privilege in vaccine refusal

5 hours ago

Not all students returning to school this month will be up to date on their vaccinations. A new study conducted by Jennifer Reich, a researcher at the University of Colorado Denver, shows that the reasons why children may ...

Using computers to design drugs

Aug 22, 2014

Designing a new medicine is an expensive and time consuming business. Typically it takes around $2 billion and ten years for a new drug to move from its initial design in the lab, to the clinic. All the ...

Lilly psoriasis drug fares well in late-stage test

Aug 22, 2014

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

User comments